Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Presence of particulate matter: potential presence of metal particulates in the product.
Consumers and healthcare providers should stop using this product immediately. Contact Merck Sharp & Dohme LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Merck Emend (aprepitant) is a prescription medication used to prevent nausea and vomiting caused by chemotherapy. Patients typically use it as part of a treatment regimen for cancer.
The recall is due to the potential presence of metal particulates in the oral suspension, which can pose serious health risks if ingested. Consumers may experience adverse health effects from consuming contaminated products.
This recall is not part of a broader industry pattern.
Consumers should stop using the medication immediately to avoid potential health risks. The recall may cause inconvenience for patients needing nausea control during chemotherapy.
The lot number and expiration date are usually found on the packaging or label of the medication.
Expect refund processing to take approximately 4 to 6 weeks after your request is submitted.
Keep a record of purchase receipts and any correspondence regarding the recall for future reference.
The recalled product is Merck Emend (aprepitant) for oral suspension, 125 mg, in a single-dose kit. The lot number is Z014503, and it expires on November 15, 2027. The product was distributed nationwide in the USA.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan North America, Inc. recalled certain 2025 Pathfinder vehicles due to faulty brake calipers on July 3, 2026. This defect can lead to a loss of front brake function, significantly increasing crash risk. Owners received notification letters on May 9, 2025.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.